Selectis Health delays Q2 2026 quarterly report

Selectis Health, Inc. (GBCS) notified regulators that it will not file its Quarterly Report on Form 10‑Q for the period ended June 30, 2026 within the prescribed time.

Rhea-AI Filing Summary

Selectis Health, Inc. (GBCS) notified regulators that it will not file its Quarterly Report on Form 10‑Q for the period ended June 30, 2026 within the prescribed time. The company states it has not yet completed preparation of its unaudited financial statements for the fiscal quarter, which prevents timely filing.

The notice is made under Rule 12b‑25, which provides a limited extension when a report cannot be filed without unreasonable effort or expense. The company identifies no specific items or transactions in this notice beyond the delayed completion of its quarterly financial statements.

Key Figures

Reporting period end: June 30, 2026 Notice date: August 17, 2026 Form type: Form 10-Q +1 more

4 metrics

Reporting period end June 30, 2026 Quarterly period covered by the delayed Form 10-Q

Notice date August 17, 2026 Date the NT 10-Q notification was signed

Form type Form 10-Q Quarterly report that could not be filed on time

Rule reference Rule 12b-25 Rule under which late-filing relief is sought

Key Terms

Rule 12b-25, unaudited financial statements, results of operations

3 terms

Rule 12b-25 regulatory

"If the subject report could not be filed without unreasonable effort or expense"

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

unaudited financial statements financial

"because the Company has not completed the preparation of its unaudited financial statements"

Unaudited financial statements are company-prepared reports of financial activity—such as income, expenses, assets and liabilities—that have not been examined or certified by an independent auditor. They offer a quicker, internal snapshot of performance, like a homeowner’s informal monthly budget compared with a bank-verified tax return. Investors use them to track recent trends and short-term results, but they carry less external verification than audited statements.

results of operations financial

"anticipated that any significant change in results of operations"

"Results of operations" show how well a company is doing over a certain period, like a report card for its business activities. It includes things like sales, profits, and expenses, helping investors see if the company is growing or struggling. This information matters because it helps people decide if they want to invest in or support the company.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Selectis Health, Inc. (GBCS) file an NT 10-Q notice?

Selectis Health filed the NT 10-Q because it could not timely file its Form 10-Q. The company states it has not completed preparation of its unaudited financial statements for the fiscal quarter ended June 30, 2026, which prevents meeting the original deadline.

What reporting period does Selectis Health’s (GBCS) late Form 10-Q cover?

The late Form 10-Q for Selectis Health covers the fiscal quarter ended June 30, 2026. The company explains in the notification that it has not completed the related unaudited financial statements needed for inclusion in that quarterly report.

Under what rule did Selectis Health (GBCS) request filing relief for its Form 10-Q?

Selectis Health requested relief under Rule 12b‑25, which allows extra time to file certain reports. The company states that it cannot file its Form 10-Q for the quarter ended June 30, 2026 on time because its unaudited financial statements are not yet completed.

Does the NT 10-Q for Selectis Health (GBCS) describe specific financial results?

The NT 10-Q does not present specific financial results or earnings figures. It states only that Selectis Health has not finished preparing its unaudited financial statements for the quarter ended June 30, 2026, which delays filing the full report.

Who signed Selectis Health’s (GBCS) NT 10-Q notification of late filing?

The notification of late filing was signed on behalf of Selectis Health, Inc. by Krystal Eckhard. The signature block is dated August 17, 2026, indicating when the company formally submitted the notice regarding its delayed Form 10-Q.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2026 - 06:02 AM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 12b-25

SEC File Number 0-15415

CUSIP Number 816291108

NOTICE OF LATE FILING

(Check One):

☐ Form 10-K ☐ Form 11-K ☐ Form 20-F ☒ Form 10-Q ☐ Form N-SAR

For Period Ended: June 30, 2026

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A

Part I—Registrant Information

Full Name of Registrant: Selectis Health, Inc.

Former Name if Applicable:

Address of Principal Executive Office (Street and Number):

600 17^th St., Suite 2800

Denver, CO 80202

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Part II—Rules 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12(b)-25(b), the following should be completed. (Check box if appropriate)

(a)	☐	The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
(b)	☒	The subject annual report or semi-annual report/portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report/portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
(c)	☐	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

Part III—Narrative

State below in reasonable detail the reasons why form 10-K, 11-K, 20-F, 10-Q or N-SAR or portion thereof could not be filed within the prescribed time period.

The Registrant is unable to file its Quarterly Report on Form 10-Q within the prescribed time period because the Company has not completed the preparation of its unaudited financial statements for the fiscal quarter.

Part IV—Other Information

(1) Name and telephone number of person to contact in regard to this notification

Clifford L. Neuman, P.C.

8300 Greenwood Dr.

Niwot, Colorado 80503

(303) 588-3978

(2)	Have all other period reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
	☒ Yes ☐ No
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
	☐ Yes ☒ No

If so; attach an explanation of the anticipated change, both narratively and quantitively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

SELECTIS HEALTH, INC.

(Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date:	August 17, 2026	By:	/s/ Krystal Eckhart
			Krystal Eckhard, VP